文献速递儿童神经与发育行为儿童内分泌与遗传代谢

基因组与发育模型预测自闭症儿童的认知与适应结局

Genomic and Developmental Models to Predict Cognitive and Adaptive Outcomes in Autistic Children.
PubMed 文献 · JAMA Pediatr · 2025-01-01

该预后研究整合遗传变异与发育里程碑,在三个自闭症队列中建立并验证预测智力障碍(ID)的模型。模型整体区分度中等(AUROC 0.653),但某些遗传变异组合可达到55%的阳性预测值,且遗传变异对ID概率的分层能力在发育迟缓个体中更高。

要点

  • 整合遗传与发育信息的模型预测自闭症儿童ID的AUROC为0.653。
  • 通常不被临床实验室重视的遗传变异组合可达55%阳性预测值。
  • 遗传变异对ID概率的分层能力在发育迟缓个体中提高达2倍。

核心结论

  • 多数情况下神经发育相关变异不能单独用于预测ID,但结合发育里程碑的模型可提供有临床意义的个体化预测。

研究设计与样本

  • 预后研究,在SPARK、Simons Simplex Collection和MSSNG三个自闭症队列中训练、交叉验证并测试模型。
  • 共纳入5633名自闭症参与者(男性4574名,81.2%),平均自闭症诊断年龄4岁(IQR 3-7),ID评估年龄11岁(IQR 8-14),1159名(20.6%)诊断为ID。
  • 预测因子包括达到早期发育里程碑的年龄、语言退化的发生、认知能力和自闭症的多基因评分、罕见拷贝数变异、影响约束基因的新发功能丧失和错义变异。

主要发现

  • 整合所有预测因子的模型AUROC为0.653(95% CI 0.625-0.681),预测性能在不同队列间交叉验证和泛化。
  • 通常不被诊断实验室认为临床相关的遗传变异组合达到55%的阳性预测值,并正确识别10%的发展为ID的个体。
  • 将多基因评分加入发育里程碑仅提高阴性预测值而非阳性预测值。
  • 使用遗传变异对ID概率进行分层的能力在发育迟缓个体中比典型发育个体高达2倍。

临床怎么用

  • 模型结合不同类别遗传变异与发育里程碑,可提供个体化ID风险预测,有助于针对性地早期干预。

局限性

  • 模型整体预测性能中等(AUROC 0.653),仅部分个体携带大效应变异、高多基因评分或发育迟缓。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Although early signs of autism are often observed between 18 and 36 months of age, there is considerable uncertainty regarding future development. Clinicians lack predictive tools to identify those who will later be diagnosed with co-occurring intellectual disability (ID). OBJECTIVE: To predict ID in children diagnosed with autism. DESIGN, SETTING, AND PARTICIPANTS: This prognostic study involved the development and validation of models integrating genetic variants and developmental milestones to predict ID. Models were trained, cross-validated, and tested for generalizability across 3 autism cohorts: Simons Foundation Powering Autism Research (SPARK), Simons Simplex Collection, and MSSNG. Autistic participants were assessed older than 6 years of age for ID. Study data were analyzed from January 2023 to July 2024. EXPOSURES: Ages at attaining early developmental milestones, occurrence of language regression, polygenic scores for cognitive ability and autism, rare copy number variants, de novo loss-of-function and missense variants impacting constrained genes. MAIN OUTCOMES AND MEASURES: The out-of-sample performance of predictive models was assessed using the area under the receiver operating characteristic curve (AUROC), positive predictive values (PPVs), and negative predictive values (NPVs). RESULTS: A total of 5633 autistic participants (4574 male [81.2%]) were included in this analysis. On average, participants were diagnosed with autism at 4 (IQR, 3-7) years of age and assessed for ID at 11 (8-14) years of age, with 1159 participants (20.6%) being diagnosed with ID. The model integrating all predictors yielded an AUROC of 0.653 (95% CI, 0.625-0.681), and this predictive performance was cross-validated and generalized across cohorts. This modest performance reflected that only a subset of individuals carried large-effect variants, high polygenic scores, or presented delayed milestones. However, combinations of genetic variants that are typically not considered clinically relevant by diagnostic laboratories achieved PPVs of 55% and correctly identified 10% of individuals developing ID. The addition of polygenic scores to developmental milestones specifically improved NPVs rather than PPVs. Notably, the ability to stratify ID probabilities using genetic variants was up to 2-fold higher in individuals with delayed milestones compared with those with typical development. CONCLUSIONS AND RELEVANCE: Results of this prognostic study suggest that the growing number of neurodevelopmental condition-associated variants cannot, in most cases, be used alone for predicting ID. However, models combining different classes of variants with developmental milestones provide clinically relevant individual-level predictions that could be useful for targeting early interventions.

来源:JAMA Pediatr,查看原文。版权归原作者所有。

引用

  1. Bourque VR, Schmilovich Z, Huguet G, et al. Genomic and Developmental Models to Predict Cognitive and Adaptive Outcomes in Autistic Children. JAMA Pediatr. 2025. PMID: 40257807. doi:10.1001/jamapediatrics.2025.0205

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。